Barclays PLC Merck & Co., Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Barclays PLC holds 4,800 shares of MRK stock, worth $476,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,800

Previous 149,600 96.79%

Holding current value

$476,976

Previous $17 Million 96.79%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$111.15 - $128.97 $129 Million - $149 Million	-1,157,249 Reduced 14.39%	6,887,575 $782 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $77.6 Million - $83.4 Million	-626,983 Reduced 7.23%	8,044,824 $996 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $362 Million - $422 Million	3,196,476 Added 58.38%	8,671,807 $1.14 Billion
Q4 2023 Feb 15, 2024	SELL	$100.18 - $109.02 $128 Million - $139 Million	-1,277,952 Reduced 18.92%	5,475,331 $597 Million
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $51.6 Million - $57.4 Million	-501,631 Reduced 6.91%	6,753,283 $695 Million
Q2 2023 Aug 03, 2023	BUY	$108.61 - $118.38 $509 Million - $555 Million	4,690,304 Added 182.89%	7,254,914 $837 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $579 Million - $646 Million	-5,620,218 Reduced 68.67%	2,564,610 $273 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $342 Million - $439 Million	3,912,091 Added 91.56%	8,184,828 $908 Million
Q3 2022 Nov 03, 2022	BUY	$84.53 - $94.96 $128 Million - $144 Million	1,511,286 Added 54.73%	4,272,737 $368 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $125 Million - $141 Million	-1,491,438 Reduced 35.07%	2,761,451 $252 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $324 Million - $363 Million	-4,402,826 Reduced 50.87%	4,252,889 $349 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $142 Million - $178 Million	1,961,749 Added 29.31%	8,655,715 $663 Million
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $142 Million - $157 Million	1,985,377 Added 42.17%	6,693,966 $503 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $68.9 Million - $76.2 Million	979,898 Added 26.28%	4,708,589 $366 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $57.6 Million - $67.8 Million	836,407 Added 28.92%	3,728,691 $287 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $64.3 Million - $71.4 Million	-896,364 Reduced 23.66%	2,892,284 $237 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $140 Million - $159 Million	1,911,413 Added 101.82%	3,788,648 $314 Million
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $44.4 Million - $50.5 Million	-630,627 Reduced 25.15%	1,877,235 $145 Million
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $193 Million - $268 Million	-3,053,746 Reduced 54.91%	2,507,862 $193 Million
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $68.5 Million - $77.3 Million	882,847 Added 18.87%	5,561,608 $506 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $7.43 Million - $8.1 Million	97,624 Added 2.13%	4,678,761 $394 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $14.7 Million - $17.2 Million	-210,633 Reduced 4.4%	4,581,137 $384 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $7.05 Million - $8.04 Million	101,342 Added 2.16%	4,791,770 $399 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $43.7 Million - $50.7 Million	-670,046 Reduced 12.5%	4,690,428 $358 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $46.5 Million - $54.7 Million	805,672 Added 17.69%	5,360,474 $380 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $118 Million - $138 Million	-2,319,111 Reduced 33.74%	4,554,802 $276 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $23.6 Million - $27.5 Million	-463,661 Reduced 6.32%	6,873,913 $374 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $196 Million - $234 Million	3,792,212 Added 106.96%	7,337,574 $413 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $208 Million - $224 Million	3,545,362	3,545,362 $227 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account